Oniam

What Oniam does

Oniam (Office National d'Indemnisation des Accidents Médicaux, des Affections Iatrogènes et des Infections Nosocomiales) is a French public administrative establishment created by the law of March 4, 2002, headquartered in Montreuil, France. Its mission is to organize the amicable, rapid, and free compensation of victims of medical accidents, nosocomial infections, and iatrogenic conditions across France. The organization operates a core indemnity service through a nationwide network of Regional Conciliation and Compensation Commissions (CCI) covering all French regions and overseas territories, with statutory deadlines of 6 months for CCI opinions, 4 months for compensation offers, and 1 month for payment after acceptance. Beyond its core medical accident compensation mandate, ONIAM manages specialized programs for benfluorex (Mediator) victims, sodium valproate victims, mandatory vaccination injuries (H1N1, COVID-19, Mpox), and HIV/hepatitis contamination from blood transfusions. Supporting instruments include the Référentiel Indicatif d'Indemnisation (indicative compensation reference framework) and the Observatoire des Risques Médicaux (medical risks observatory).

The organization's business model is structured as a publicly funded entity rather than a commercial enterprise. ONIAM's funding flows from four sources: a global allocation (dotation globale) from health insurance organizations set annually by the social security financing law, state allocations for specific missions (mandatory vaccinations, emergency health measures, benfluorex), contributions from the Etablissement Français du Sang for hepatitis C contamination compensation, and reimbursement/penalty revenues recovered from responsible parties. The service is provided free of charge to victims, with legal representation optional and at the victim's expense. ONIAM is governed by a Board of Directors (Conseil d'Administration) composed of government representatives, healthcare professionals, patient representatives, and elected staff representatives, and is subject to administrative, budgetary, and financial controls. Partnerships with insurance federations (FFSA, GEMA), the French Blood Agency (EFS), patient associations (APESAC, CADUS), and primary health insurance funds (CPAM) form an institutional ecosystem that supports case identification and processing.

Name

Oniam

Legal name

Office National d'Indemnisation des Accidents Médicaux, des Affections Iatrogènes et des Infections Nosocomiales

Website

https://oniam.fr

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

101–250 employees

Short description

Oniam is a French public administrative establishment, created in 2002, that provides free, rapid, and amicable compensation to victims of medical accidents, nosocomial infections, iatrogenic conditions, vaccination injuries, and pharmaceutical-related harms across France.

Ownership category

akta.pro rank

Product category

Government Medical Accident Compensation Services

NAICS

Justice, Public Order, and Safety Activities (922)

SIC

Accident & Health Insurance (6321)

akta.pro industry

PRIMARYHLAJAMAE

Regulatory Compliance, Licensing & Enforcement (Public Health)

Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Policy & Administration

Keywords

• Medical accident compensation
• Nosocomial infection indemnity
• Iatrogenic condition claims
• Vaccination injury compensation
• Public health indemnity

Headquarters

HQ city

Montreuil

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Others

Revenue model

1. Global allocation from health insurance: ONIAM receives a global allocation (dotation globale) from health insurance organizations, with annual amounts set by the social security financing law. The allocation is distributed according to rates fixed annually under Article R. 174-1-4 of the Social Security Code.
2. State allocations: State funding for mandatory vaccination compensation, emergency health measures compensation, and benfluorex-related compensation.
3. Etablissement Français du Sang contribution: Funding from the French Blood Agency covering hepatitis C contamination compensation expenses.
4. Reimbursement and penalties: Reimbursement of expert fees, penalties from healthcare providers, and subrogation rights recovered from responsible parties.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

ONIAM is a French public administrative establishment that provides free, rapid, and amicable (out-of-court) compensation to victims of medical accidents, iatrogenic conditions, and nosocomial infections. It processes claims through regional Commissions de Conciliation et d'Indemnisation (CCI), determines compensation amounts using a standardized référentiel indicatif d'indemnisation, and manages specialized programs for benfluorex (Mediator), sodium valproate, mandatory vaccination injuries (H1N1, COVID-19, Mpox), and blood contamination cases (HIV, Hepatitis B/C, HTLV).

Product overview

Oniam (Office National d'Indemnisation des Accidents Médicaux, des Affections Iatrogènes et des Infections Nosocomiales) is a French public institution created by the law of March 4, 2002, serving as a single unified compensation service rather than a platform architecture. The organization provides amicable, rapid, and free compensation for victims of medical accidents through its core indemnity service and regional Commissions de Conciliation et d'Indemnisation (CCI). It also manages specialized compensation programs for specific pharmaceutical and vaccination-related cases including Benfluorex/Médiator, Sodium Valproate, mandatory vaccinations (H1N1, COVID-19, smallpox), and blood contamination cases (HIV, Hepatitis C/B, HTLV). Supporting services include the Indicative Compensation Framework (Référentiel Indicatif d'Indemnisation) for determining award amounts and the Medical Risks Observatory (Observatoire des Risques Médicaux) for tracking and analyzing medical incident trends.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Accident Compensation (Indemnisation des Accidents Médicaux) Government compensation service for victims of medical accidents, providing free, rapid, and amicable resolution of claims through regional Commissions de Conciliation et d'Indemnisation (CCI). Targeted at victims of medical accidents in France.
• Nosocomial Infection Compensation (Indemnisation des Infections Nosocomiales) Compensation service for victims of hospital-acquired infections (nosocomial infections). For patients who contracted infections during hospital or healthcare facility stays.
• Iatrogenic Condition Compensation (Indemnisation des Affections Iatrogènes) Compensation service for victims of iatrogenic conditions (adverse effects from medical treatment). For patients harmed by medical interventions or drug side effects.
• Benfluorex (Mediator) Compensation Amicable settlement service for damages caused by benfluorex (commercially known as Mediator), including Benfluorex Qualimed and Benfluorex Mylan variants. Targeted at victims of the Mediator pharmaceutical scandal.
• Sodium Valproate Compensation (Indemnisation Valproate de Sodium) Compensation for victims exposed to sodium valproate during pregnancy, covering medications including Dépakine, Dépakote, Dépamide, Micropakine and generics. Targeted at children with congenital disorders caused by in-utero valproate exposure.
• Mandatory Vaccination Accident Compensation Compensation for damages from mandatory vaccinations including influenza A (H1N1), COVID-19, and smallpox/Mpox. Targeted at victims of adverse events following mandatory vaccination campaigns in France.
• HIV Contamination Compensation (Indemnisation des Contaminations par le VIH) Compensation for victims of HIV contamination through blood transfusion or blood product injection. Targeted at victims of transfusional HIV contamination.
• Hepatitis B/C and HTLV Contamination Compensation Compensation for victims of Hepatitis C, Hepatitis B, and Human T-lymphotropic virus (HTLV) contamination through transfusion. Targeted at victims of transfusional hepatitis or HTLV contamination.
• Observatoire des Risques Médicaux (ORM) Medical risks observatory affiliated with ONIAM that measures the evolution and significance of medical accidents and infections. Serves healthcare researchers, public health officials, and patient associations.

Quantifiable outcome

• 6-month deadline for CCI to issue opinions
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered minor and core.

• EANETminorOthersEANET handles the development, hosting, and maintenance of ONIAM's official website. Located at 29, boulevard de la République, 92250 La Garenne-Colombes.
• Fédération Française des Sociétés d'Assurance (FFSA)coreOthersInsurance industry federation partner working with ONIAM for medical accident compensation when healthcare provider liability is established. Health insurers provide compensation through ONIAM's amigable procedure.
• Groupement des Entreprises Mutuelles d'Assurance (GEMA)coreOthersMutual insurance companies partner with ONIAM for compensation of medical accidents where provider responsibility is confirmed.
• Etablissement Français du Sang (EFS)coreOthersFrench Blood Agency provides funding to ONIAM for hepatitis C contamination compensation and can be consulted to verify blood transfusion records when victims' medical files have been destroyed.
• Commissions de Conciliation et d'Indemnisation (CCI)coreOthersRegional Conciliation and Compensation Commissions process medical accident compensation requests across France. ONIAM works with these commissions to evaluate claims and determine compensation eligibility.
• APESACminorOthersAssociation representing victims of sodium valproate, member of ONIAM's Orientation Council, provides support to victims in their compensation claims.
• CADUSminorOthersPatient association member of ONIAM's Orientation Council that assists victims in compensation procedures.
• Primary Health Insurance Funds (CPAM)coreOthersPrimary health insurance funds (Caisse Primaire d'Assurance Maladie) distribute ONIAM's global allocation and handle financial aspects of the compensation system under Article R. 1142-58 CSP.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Finnish Patient Insurance Centre (Potilasvakuutuskeskus): Finnish centralized body managing no-fault patient insurance claims, financed by healthcare providers. Comparable to ONIAM in providing centralized medical injury compensation with statutory frameworks.
• Swedish Patient Insurance (LÖF): Swedish no-fault patient injury insurance company providing compensation to patients suffering healthcare-related injuries. Directly comparable to ONIAM as a national, government-affiliated body handling medical accident compensation under a no-fault framework.
• Danish Patient Compensation Association: Danish organization handling patient compensation claims under the Danish Act on Complaints and Compensation in the Health Service. Operates a no-fault scheme analogous to ONIAM's.
• Norwegian System of Patient Injury Compensation (NPE): Norwegian state body that processes compensation claims from patients who have suffered injury in the healthcare system. Closely aligned with ONIAM's mandate and operating model.

Broad incumbents

• NHS Resolution: UK body handling clinical negligence claims against the NHS. While operating within a litigation-based framework rather than no-fault, NHS Resolution is comparable to ONIAM as a government-affiliated medical compensation body.
• New Zealand Accident Compensation Corporation (ACC): New Zealand's comprehensive no-fault accident compensation scheme covering all injuries including medical. While broader in scope (general accidents), ACC's structure and government-backed compensation model parallel ONIAM's approach to medical accidents.

Others

• APESAC: French association representing victims of sodium valproate and member of ONIAM's Orientation Council. Functions as a patient advocacy partner that channels victims to ONIAM's compensation process.
• Fédération Française de l'Assurance (FFA): Federation of French insurance companies partnering with ONIAM on medical accident compensation when healthcare provider liability is established. Adjacent ecosystem participant central to ONIAM's operating model.
• Ministry of Health (France): French Ministry of Health, which supervises ONIAM and sets its strategic direction via the Conseil d'Administration. ONIAM's regulatory parent and primary policy interlocutor.
• Etablissement Français du Sang (EFS): French Blood Agency that funds ONIAM's hepatitis C contamination compensation and is consulted to verify transfusion records. A core funding partner and adjacent government entity in the medical safety ecosystem.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oniam